RILPIVIRINE
rilpivirine 25 mg tablet, 30
RILPIVIRINE (10298B)
10298B
Manner of administration:Oral
Restriction 4512
Indication: HIV infection
Treatment phase: Initial
Restriction 4454
Indication: HIV infection
Treatment phase: Continuing
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $518.68 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Edurant | |||||